欧洲荧光免疫分析市场预测至 2028 年 – COVID-19 影响和区域分析 – 按产品类型（ELISA、快速侧流免疫分析等）、应用（传染病、肿瘤学、心血管疾病等）和最终用户（医院和诊所、诊断中心、制药和生物技术公司、学术和研究机构等）
No. of Pages: 168 | Report Code: BMIRE00025661 | Category: Life Sciences
No. of Pages: 168 | Report Code: BMIRE00025661 | Category: Life Sciences
欧洲荧光免疫分析市场预计将从2021年的7.8127亿美元增长到2028年的10.9071亿美元；预计 2021 年至 2028 年复合年增长率为 4.9%。
整个地区的慢性疾病和病症正在增加。对昂贵的慢性病护理的需求不断增长，对医疗保健系统提出了巨大的要求。人口老龄化的增加和社会行为的转变导致这些常见且代价高昂的长期健康问题稳步上升。中产阶级不断壮大；因此，随着城市化进程的加快，人们正在采取更加久坐的生活方式。这正在推动肥胖率和糖尿病等疾病的发生。慢性肾病 (CKD) 是第 14 大死因，每年导致 120 万人死亡。慢性肾病发病率的增加主要与高血压、心血管疾病、荷尔蒙失衡和糖尿病等生活方式障碍有关。早期发现和治疗 CKD 至关重要，因为进行性 CKD 与不幸的临床后果相关，例如终末期肾病 (ESKD)、心血管疾病和死亡率增加。 CKD 的诊断、预后和控制基于对肾小球滤过率 (GFR) 的了解。胱抑素-C 是比常用的肌酐更好的 GFR 标记物。开发并优化了荧光侧流免疫测定法，以估计半胱氨酸蛋白酶抑制剂-C 值，从而计算 GFR。 COVID-19 大流行凸显了在护理点进行快速、准确的核酸检测的必要性。此外，基于荧光的定量逆转录PCR（RT-qPCR）具有高灵敏度和特异性，但由于需要核酸纯化和扩增，周转时间可能会部分延长（从几小时到几天）。此外，大多数感染 SARS-CoV-2 的人会出现轻微症状或无症状。因此，迫切需要开发快速、简单、高通量的核酸检测方法。标准荧光免疫分析系统是一种多参数、随机访问系统，可提供准确可靠的诊断结果。它是一个能够对感染、呼吸道疾病和慢性疾病进行定性和定量分析的系统。方便的用户界面和实验室信息系统 (LIS)/医院信息系统 (HIS) 连接节省了宝贵的时间，分析仪自动读取和解释结果。截止指数为医疗决策提供了良好的参考点。因此，由于该地区慢性疾病数量不断增加，对荧光免疫分析的需求不断增长。
借助新功能和技术，供应商可以吸引新客户并扩大其业务范围新兴市场的足迹。这一因素可能会在预测期内推动欧洲荧光免疫分析市场实现显着的复合年增长率。
2028 年欧洲荧光免疫分析市场收入及预测（百万美元）
欧洲荧光免疫分析市场细分
欧洲荧光免疫分析市场按产品类型、应用、最终用户和国家/地区进行细分。根据产品类型，市场分为 ELISA、快速侧流免疫分析等。 ELISA 细分市场在 2021 年占据市场主导地位，预计在预测期内增长最快。根据应用，市场分为传染病、肿瘤、心血管疾病等。传染病领域在 2021 年占据市场主导地位，预计在预测期内增长最快。根据最终用户，市场分为医院和医疗机构。诊所、诊断中心、制药和医疗中心生物技术公司、学术界和研究机构等。医院和诊所领域在 2021 年占据市场主导地位，预计在预测期内增长最快。根据国家/地区，欧洲荧光免疫分析市场分为英国、德国、法国、意大利、西班牙和欧洲其他地区。
雅培、BD、bioMerieux SA、丹纳赫、F. Hoffmann-La Roche Ltd.、Ortho Clinical Diagnostics Holdings plc、Quidel Corporation、西门子AG、Sysmex Corporation 和 Thermo Fisher Scientific Inc. 是欧洲荧光免疫分析市场的领先公司之一。
Strategic insights for Europe Fluorescent Immunoassay involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 781.27 Million |
| Market Size by 2028 | US$ 1,090.71 Million |
| Global CAGR (2021 - 2028) | 4.9% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 产品类型
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Fluorescent Immunoassay refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Fluorescent Immunoassay Market is valued at US$ 781.27 Million in 2021, it is projected to reach US$ 1,090.71 Million by 2028.
As per our report Europe Fluorescent Immunoassay Market, the market size is valued at US$ 781.27 Million in 2021, projecting it to reach US$ 1,090.71 Million by 2028. This translates to a CAGR of approximately 4.9% during the forecast period.
The Europe Fluorescent Immunoassay Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Fluorescent Immunoassay Market report:
The Europe Fluorescent Immunoassay Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Fluorescent Immunoassay Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Fluorescent Immunoassay Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Fluorescent Immunoassay Market
